Roles of hCG in Advancing Follicular Growth to Ovulation after Concurrent Injections of PGF2α and GnRH in Postpubertal Holstein Heifers Bearing a CL by Johnson, Ricky et al.
SAGE-Hindawi Access to Research
Veterinary Medicine International
Volume 2010, Article ID 394236, 7 pages
doi:10.4061/2010/394236
Research Article
Rolesof hCGinAdvancing FollicularGrowthto Ovulation
after ConcurrentInjectionsof PGF2α and GnRHin Postpubertal
Holstein Heifers Bearinga CL
Ricky Johnson,1 WilliamA. Bennett,2 Evelin J. Cuadra,1 Victor Njiti,3 Yoonsung Jung,3
andMelissaMason1
1Department of Agriculture, Alcorn State University, 1000 ASU Drive, Box 750, Alcorn State, MS 39096, USA
2Department of Obstetrics and Gynecology, University of Mississippi Medical Center, 2500 North State Street, Jackson,
MS 39216, USA
3School of Research, Alcorn State University, 1000 ASU Drive no. 330, Alcorn State, MS 39096, USA
Correspondence should be addressed to Evelin J. Cuadra, cuadra@alcorn.edu
Received 22 June 2010; Revised 20 September 2010; Accepted 21 October 2010
Academic Editor: Philip H. Kass
Copyright © 2010 Ricky Johnson et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A study was conducted to test the hypothesis that injecting Gonadotropin-releasing hormone (GnRH) concurrently with
Prostaglandin F2 alpha (PGF2α) followed by an injection of human Chorionic Gonadotropin (hCG), would advance follicular
growth to ovulation in Holstein heifers bearing a corpus luteum (CL). After manual examination of the CL, group 1 (PGF;
n = 12) received an injection of PGF2α (25mg, im). Group 2 (PGF + GnRH; n = 13) received an injection of GnRH (100μg,
im) immediately after an injection of PGF2α. Group 3 (PGF + GnRH + hCG; n = 12) received concurrent injections of PGF2α
and GnRH followed with hCG (1500IU, im) two days later. Follicular size and day of ovulation were monitored by daily
ultrasonographic examination from days 1 to 10. Blood was collected on days-7, 0 (PGF2α administration), 2, and 7. Progesterone
was not diﬀerent (P>. 05) on days-7, 0, and 2 between the experimental groups. However, it was higher (P<. 005) in the PGF
+ GnRH + hCG group on day 7 compared to PGF + GnRH heifers, but not signiﬁcantly higher than the PGF. Additionally,
heifers in the PGF + GnRH + hCG group ovulated earlier (P<. 05) than heifers in the PGF + GnRH and the PGF group. This
data indicates that hCG advances follicular growth to ovulation in spite of high levels of progesterone when injected 48 h after
concurrent treatments of GnRH and PGF2α on heifers bearing a CL.
1.Introduction
Over the past 25 years, the use of Gonadotropin-releasing
hormone (GnRH) and Prostaglandin F2 alpha (PGF2α)
has experienced a remarkable increase in research studies
intended to manipulate ovarian cell response with the
objective to improve cattle fertility. Even though signiﬁcant
progress has been made in this line of research, timing
in the administration of GnRH in reference to PGF2α and
combination of these two hormones with others, are some
of the topics of research at present. Thus, studies have been
conducted in an attempt to improve pregnancy rates in
CoSynch protocols by extending or reducing the intervals
between GnRH injections and the PGF2α. Research trials
have demonstrated the eﬀectiveness of these protocols in
improving pregnancy rates when PGF2α is injected 7 days
after administration of the ﬁrst GnRH [1, 2]. Additionally,
as t u d yc o n d u c t e db yag r o u po fi n v e s t i g a t o r s[ 3] showed
that extending the interval between the ﬁrst GnRH and
the PGF2α does not reduce the variability in response to
synchronization of ovulation in heifers. However, others
observed that extending the administration of the second
GnRH to 48h after the PGF2α improved pregnancy rate
[4]. On the other hand, drastically decreasing the interval
between the ﬁrst GnRH and PGF2α may aﬀect fertility.
This is supported by ﬁndings indicating that the proba-
bility of pregnancy decreases substantially in dairy cows
experiencing an incomplete corpus luteum (CL) regression2 Veterinary Medicine International
[5]. The detrimental factor is the relatively high levels of
progesterone secreted by luteal tissue as a consequence of an
incomplete luteolysis [6] which in turn, reduces the ability
of endogenous estradiol to induce a preovulatory surge of
luteinizing hormone (LH) and ovulation [7]. High levels of
progesteroneareobservedafterconcurrentadministrationof
these two hormones due to either an incomplete regression
oftheCL[6]orformationofnewlutealtissueindairyheifers
[8, 9]. Furthermore, GnRH improved estrus synchrony in
beef cattle when injected 7 days prior to a GnRH-PGF2α
protocol [10], but failed to improve estrus response or
synchrony of estrus in beef heifers when administered 7 days
prior to a 14–19 day melengestrol acetate—PGF2α treatment
[11]. This diﬀerence in GnRH action may be associated with
the development of persistent follicles during MGA feeding
[2].
In studies where GnRH has been replaced by human
Chorionic Gonadotropin (hCG) in Cosynch protocols,
pregnancy rates have been greatly reduced in beef cows
[12]. Controversially, other studies revealed signiﬁcantly
lower implantation rate and signiﬁcantly higher rate of
early pregnancy loss in patients induced to ovulate with
a GnRH agonist when compared to those treated for the
same purpose with hCG [13]. However, data reported by
others [14] revealed no diﬀerences in the use of either
GnRH or hCG to eﬀectively induce ovulation in lactating
dairy cows. Similar results were observed in studies where
the second GnRH in TAI was replaced by hCG in dairy
heifers [4]. In contrast, others reported [15] hCG being
more eﬀective than GnRH in its ability to ovulate follicles,
increase volume of luteal tissue in the subsequent developing
CL, and concentrations of progesterone in prepubertal
heifers.
It has been suggested that systemic levels of progesterone
play a role in modulating the outcome in the use of
hCG to induce ovulation in cattle [7]. Additionally, it is
reported that expression of genes involved in the process
of steroidogenesis was signiﬁcantly increased in the CL
of cows treated with pLH [16]. This seems to be in line
with ﬁndings reported which revealed that serum levels
of both estradiol and progesterone increase in response to
an ovulatory dose of hCG in rats [17]. Moreover, high
progesterone concentrations were observed in prepubertal
Angus heifers [15] and in lactating dairy cows [18]i n
response to hCG-induced ovulations.
Dynamics of follicular development and growth has
been associated with LH in several research studies. Thus,
an increase in follicular development has been observed
in nonhuman primates after administration of exogenous
LH [19]. Additionally, treatment of heifers with 3,000
IU of hCG on day 5 of the estrous cycle were reported
to extend the life of the preovulatory follicles [20], to
induce formation of a heavier accessory CL and to cause
a linear increase of plasma progesterone from day 6 to
13 when compared to a GnRH agonist treatment [21].
Other researchers [22] stated that the role played by hCG is
limited to the development of antral follicles. Nevertheless,
it was also indicated that the need of LH for antral follicle
maturationisdubious[19].Furthermore,otherinvestigators
suggested that the response of the ovarian cells to hCG
is mediated by the day of the estrous cycle when hCG
is administered [23–26]. This trial was meant to evaluate
the eﬀects of hCG in advancing follicular development to
ovulation in dairy heifers with progesterone levels similar
to concentrations observed in early diestrus [27]. Other
researchers observed alteration of the follicles dynamic in
nonbred lactating cows receiving hCG on day 7 of the
estrous cycle [28]; in that study, the time of emergence
of the second wave of follicular growth was advanced in
the group of cows receiving hCG treatment. Additionally,
administration of hCG 7 days post insemination was sug-
gested to improve embryo retention in cattle by boosting
plasma progesterone concentration as a consequence of
inducing formation of an accessory corpus luteum [29]. An
additional objective of the present study was to elucidate the
mechanism used by GnRH on ovarian tissue to maintain
systemic progesterone levels despite the luteolytic eﬀects of
PGF2α when both hormones are injected concurrently in
cattle.
2.MaterialsandMethods
2.1. Experimental Design and Hormonal Protocol. Thirty-
seven cycling postpubertal Holstein heifers were randomly
allotted by weight, age, body condition score and after
manual examination of the CL, to one of three treatments
to test the hypothesis that injecting hCG aftera simultaneous
administrationofGnRHandPGF2α wouldadvancefollicular
growth and ovulation time in heifers bearing a CL. Heifers
in the study were selected from a larger pool of cycling
animals by meeting the following criteria: (a) progesterone
concentration in the blood of at least 3ng/ml seven days
before PGF2α was administered (day-7); (b) heifers should
be bearing a well-developed CL on day 0 (administration of
PGF2α). The study was approved by the Institutional Animal
Care and Use Committee of Alcorn State University (A3810-
01). Body condition among heifers was established between
3a n d4( B C S1=thin, BCS 5=obese) prior to the beginning
of the study. Heifers in the control group (PGF; n = 12)
received a single injection of PGF2α (25mgim; Lutalyse;
Pharmacia Upjohn Company) designed as day 0 of the study.
The second group (PGF+GnRH; n = 13) additionally
received an injection of GnRH (100μg im; Cystorelin; Sanoﬁ
Winthrop) immediately after the injection of PGF2α.H e i f e r s
in the third group (PGF+GnRH+hCG; n = 12) received
the same GnRH and PGF2α treatments as heifers in group
2; however, these heifers received an additional injection of
hCG (1500IU, im; Gonakor, Laboratorios Sanfer) 48h after
the injection of PGF2α (day 2).
2.2. Collection of Blood Samples. Blood sample collection
for progesterone and estrogen determination was initiated
a week before the injection of PGF2α (day-7); subsequent
samples were collected on days 0, 2, and 7. Blood samples
were collected by tail vein puncture and were immediately
centrifuged for plasma separation.Veterinary Medicine International 3
Table 1: Means and standard errors for size (mm) of ovulating follicle and days to ovulation.
Treatment N Follicle size Days to ovulation∗
Day 0 Day 2 Preovulation∗∗
PGF 11 2.79 ±0.99a 2.80 ±0.09a 11.0 ±0.8a 5.70 ±0.42a
PGF+GnRH 11 2.78 ±1.04a 2.82 ±0.08a 10.7 ±1.1a 5.00 ±0.56a
PGF+GnRH+hCG 11 2.77 ±1.04a 2.81 ±0.09a 11.1 ±0.6a 3.64.1 ±0.34b
aMeans within the same column lacking a common superscript are signiﬁcantly diﬀerent (P<. 05)
∗Days from injection of PGF2α
∗∗2 4hb e f o r eo v u l a t i o n .
2.3. Progesterone and Estrogen Assays. Plasma samples
were analyzed for progesterone concentration via radioim-
munoassay. Progesterone assays were performed using a
commercial enzyme immunoassay kit provided by Oxford
BiomedicalResearch(Oxford,Michigan).Thisisanenzyme-
linked immunosorbent assay that operates on the basis of
competition of solid-phase RIA system relying upon com-
petitive binding between a radioactive and nonradioactive
antigen for a ﬁxed number of antibody sites coated to the
assay tubes. The speciﬁcity of this assay as reported by the
manufacturer was 100% cross reactivity with progesterone,
2.5% with deoxycorticosterone, 2.0% with corticosterone,
2.0% with pregnenolone, 1.0% with androstenedione and
lessthan1.0%withothersteroidhormonestested.Therange
of the progesterone assay used for this study was between 0
and 60ng/ml. The assay displayed a sensitivity of 0.12ng/ml
and an average recovery rate of 97%. Average inter- and
intra-assay coeﬃcients of variability were 8.03 and 11.7 5%,
respectively.
Concentrations of estradiol in plasma samples were
determined by radioimmunoassay. The procedure follows
the basic principle of radioimmunoassay where there is
competition between a radioactive and a nonradioactive
antigen for a ﬁxed number of antibody binding sites. The
amount of [I-125]-labeled estradiol bound to the antibody
is inversely proportional to the concentration of the estradiol
present. Separation of free and bound antigen was achieved
by using a double antibody system. Cross-reactivity of the
estradiol antiserum has been detected at 2.40% with estrone,
3.40% with equilin, 2.56% with keto-estradiol and less than
1.0% with other steroid hormones tested.
2.4. Imaging of the Ovaries. Transrectal examination of
follicular growth and day of ovulation was performed daily
on both ovaries by real-time ultrasonography using an Aloka
500v; it started on day 1 and continued up to day 10 of the
study. Diameters of ovulating follicles were measured (mm)
using a caliper on images obtained the day before ovulation;
day of ovulation was determined by visual observation on
images.
2.5. Statistical Analysis. Data collected on age, body weights,
and body condition scores were analyzed using the anal-
ysis of variance (ANOVA) procedure. Data obtained on
progesterone and estrogen levels in blood were analyzed
using the GLM repeated measures analysis (SAS Institute.,
1991).Thecorrelationbetweenhormoneconcentrationsand
days to ovulations was also evaluated using the SAS CORR
procedure. Correlation between follicle size on days 0 and 2
with days to ovulations was also evaluated. LSD was used to
test diﬀerences among and within treatments.
3. Results
There were not any signiﬁcant diﬀerences (P>. 05) in
body weights (Kg; Mean±S.E.) between heifers allocated
in the PGF group (384.09 ± 18.4), PGF+GnRH group
(387.27±20.9)andthePGF+GnRH+hCGgroup(381.59±
13.6). Also, body condition scores for heifers were not
diﬀerent among the PGF (3.3±0.1), PGF+GnRH (3.4±0.1)
andPGF+GnRH+hCGgroups3(3.4 ±0.1).
Table 1 shows means and standard errors for size (diam-
eter, mm) of the ovulating follicle on days 0, 2 and on the
day before ovulation as well as days to ovulation. Size of
the ovulating follicles in the three experimental groups on
days 0 and 2 were not diﬀerent (P>. 05). Additionally, size
of the ovulating follicles of heifers in the PGF group 24h
before ovulation (11.0 ± 0.8mm) not signiﬁcantly diﬀerent
(P>. 05) than the increases in size experienced by the
ovulating follicles before rupture in PGF+GnRH (10.7 ±
1.1mm) and PGF+GnRH+hCG groups (11.1 ± 0.6mm).
Days to ovulation were measured in heifers ovulating within
theﬁrst8daysofthestudyasthenumberofdaysbetweenthe
injection of PGF2α and the rupture of the ovulating follicle.
TheexperimentalgroupreceivinghCGovulatedsigniﬁcantly
earlier (3.64 ± 0.34 day; P<. 05) than heifers allocated in
the PGF (5.70 ± 0.42) and the PGF+GnRH (5.00 ± 0.56)
groups. There were no signiﬁcant diﬀerences in ovulating
time between the PGF and PGF+GnRH heifers (P>. 05).
Size of follicles on days 0 and 2 in the ovulating heifers were
not correlated to days to ovulation (P>. 05).
Table 2 shows means and standard errors for pro-
gesterone concentrations between treatments and within
treatments on heifers ovulating during the ﬁrst 8 days of the
study. Progesterone levels signiﬁcantly dropped (P<. 05) on
day d2 (2.50 ± 0.77ng/ml) in the PGF heifers in response to
the injection of PGF2α on day 0 (7.03 ± 0.96); then, it went
up on day 7 (5.65 ± 0.83) but not signiﬁcantly higher (P>
.05).ProgesteronealsodroppedsigniﬁcantlyinPGF+GnRH
heifers from 8.96 ± 1.48 on day 0 to 3.99 ± 1.0o nd a y2
(P<. 05). Levels observed on day 2 were not signiﬁcantly
diﬀerent from those on day 7 (3.03 ± 0.71; P>. 05) for that4 Veterinary Medicine International
Table 2: Means and standards errors for progesterone concentrations in ovulating heifers by treatment and by day (ng/ml).
Treatment N Day-7 Day 0∗ Day 2 Day 7
PGF 11 7.19 ±1.68aε  7.03 ±0.96aε  2.50 ±0.77a£ 5.65 ±0.83abε £
PGF+GnRH 11 6.37 ±1.17aε £ 8.96 ±1.48aε  3.99 ±1.00a£γ 3.03 ± 0.71aγ
PGF+GnRH+hCG 11 5.72 ±1.18aε £ 6.34 ±1.29aε £ 3.78 ±1.34a£ 9.04 ±1.85bε 
a,bMeans within the same column lacking a common superscript diﬀer (P<. 05)
ε ,£,γMeans within the same row lacking a common symbol diﬀer (P<. 05)
N:Numberofheifers
∗Injection of PGF2α.
Table 3: Number ovulations by treatment and by day.
Treatment N Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
PGF 1 1 00103412
PGF+GnRH 1 1 11205020
PGF+GnRH+hCG 1 1 10531100
same group. On the other hand, PGF+GnRH+hCG heifers
did not experience a signiﬁcant decline in progesterone
levels from day 0 (6.34 ± 1.29) to day 2 (3.78 ± 1.34;
P>. 05). Nevertheless, progesterone levels for this group
of heifers on day 7 (9.04 ± 1.85), were signiﬁcantly higher
than levels observed on day 2 (P<. 05). No signiﬁcant
diﬀerences (P>. 05) were observed for plasma progesterone
levels between the three experimental heifers on days-7, 0
and 2. Nevertheless, progesterone levels were signiﬁcantly
higher on day 7 for heifers in the PGF+GnRH+hCG
g r o u pc o m p a r e dt ot h eP G F + G n R Hg r o u p( P<. 05)
on that day. The increases in progesterone concentrations
(ng/ml) experienced by the PGF (3.16 ± 1.03) and the
PGF+GnRH+hCG (5.26 ± 1.33) groups from day 2 to
day 7, were not signiﬁcantly diﬀerent (P>. 5); however,
both groups hada signiﬁcant higherincrease in progesterone
when compared to the change experienced on those same
days by heifers receiving PGF+GnRH (−0.96 ±1.07ng/ml).
Table 3 shows number of heifers ovulating by treatment
andbydayofthestudy.Ovulationoccurredin7outofthe11
ovulatingheifersinthePGFgroupbetweenday5and6while
the majority (8/11) of heifers in the PGF+GnRH+hCG
group ovulated between day 3 and 4. However, the highest
number of ovulations in the PGF+GnRH animals occurred
on day 5 of the experiment (5/11). Other animals receiving
this experimental treatment ovulated more than 48h apart
fromtheanimalsovulatingonday5.Outofthetotalnumber
of heifers alloted to each experimental group, one heifer
in the PGF and one in PGF+GnRH+hCG group did not
ovulate within the ﬁrst 8 days of the study; two also did not
ovulate in PGF+GnRH group within the same period.
Estrogen concentrations in plasma were not statistically
diﬀerent (P>. 05) between heifers in the three experimental
groups on days-7, 0, 2, and 7. However, overall estrogen
concentrations and concentrations on days 2 and 7 were
correlated (P<. 05) with days to ovulation (Table 4). Table 4
also shows a correlation between overall and day 7 plasma
progesterone with days to ovulation (P<. 05).
4. Discussion
There were no signiﬁcant diﬀerences in size of the ovulating
follicles on days 0, 2 or on the day before ovulation amongst
heifers allotted to the three experimental treatments. Nev-
ertheless, follicles in heifers receiving hCG, reached the
ovulating size earlier than the other two groups of heifers
in the study; as a consequence, these heifers also ovulated
signiﬁcantly earlier than animals in the other two exper-
imental groups. This data suggests that administration of
hCG plays a role in advancing follicular growth to ovulation
and in promoting follicular growth. Levels of progesterone
in this group were 3.78 ± 1.34ng/ml on day 2 when hCG
was administered and went up 5 days later (day 7) to
9.04 ± 1.85. However, data previously reported revealed
that progesterone concentrations of 1.20ng/ml inhibited
ovulation in lactating cows treated 12 days apart with two
injections of PGF2α and an injection of estradiol cypionate
two days after the ﬁrst injection of PGF2α [7]. These inves-
tigators concluded that progesterone reduced the ability of
endogenous or exogenous estradiol to induce a preovulatory
LH surge and ovulation. Furthermore, other investigators
reported that cows with progesterone concentrations greater
than 1ng/ml before treatment with either hCG or GnRH
tend to ovulate less often than those having progesterone
levels below 1ng/ml [30]. Nevertheless, the group receiving
the PGF+GnRH+hCG treatment in the present study
ovulatedearlierthantheothertwoexperimentalgroupseven
though progesterone levels were higher (3.78 ± 1.34) than
1ng/ml.Thus,ourﬁndingsdemonstratethatthemechanism
previously proposed [7] can be overridden by exogenous
administration of hCG by acting directly on follicular tissue
[31]. This data also indicate that cows receiving GnRH,
followed 48h later with hCG, would advance to ovulation
at progesterone concentrations much higher than 1ng/ml at
time of the hCG treatment.
Our results agree with data reported by researchers
[17] who induced ovulation in women, beef cows [30],
and dairy heifers [32] treated with hCG injections. InVeterinary Medicine International 5
Table 4: Pearson correlation coeﬃcients: days to ovulation X hormone concentration by day (correlation value/P-value).
Hormone Day-7 Day 0 Day 2 Day 7 Overall
Progesterone −0.02975 −0.10803 −0.33603 −0.39587 −0.25876
(ng/ml) 0.1040 0.5629 0.0646 0.0275 0.0037
Estrogen −0.05859 0.23097 0.41938 0.37511 0.26333
(pg/ml) 0.7542 0.2113 0.0188 0.0376 0.0275
Signiﬁcant Diﬀerent at P<. 05.
addition, our data is also in line with research ﬁndings
whichsuggestthathCGselectivelystimulatesfolliculogenesis
and induces ovulation in women [33]. Furthermore, other
investigators [22] concluded that hCG actions are more
selectively associated with follicles in advanced stages of
development.
The criteria previously described for selecting heifers
participating in this study resulted in progesterone concen-
trations for the three groups on day 0 comparable to those
observed in heifers with a functional CL (8.2 ± 0.3ng/ml)
at the end of a 14-day treatment with melengestrol acetate
[27, 34]. Mean progesterone concentrations observed in this
study for the PGF, PGF+GnRH, and PGF+GnRH+hCG
heifers (7.03 ± 0.96; 8.96 ± 1.48; 6.34 ± 1.29ng/ml) on day
0 are higher than those reported in a earlier study [27]f o r
heifers in early diestrus (between 1 and <3ng/ml). Thus, this
indicates heifers involved in the present trial were beyond the
early stage of diestrus on day 0 of this study.
As expected, progesterone levels dropped in animals in
all three experimental groups in response to the injection of
PGF2α. Nevertheless, a higher decrease in progesterone was
expected in the PGF group 48h after the injection. While
some heifers had progesterone concentrations at 48h after
PGF2α immediately above the sensitivity level of the assay,
some heifers in this group had levels higher than 1ng/ml.
This may be due to an incomplete luteolysis at the time
the blood sample was collected inﬂuenced by the level of
progesterone and by the time of the day when PGF2α was
administered. A previous study [27]h a ss u g g e s t e da7 2 h
period for complete regression of a functional CL after a
single injection of PGF2α which is aﬀected by concentrations
of progesterone.
T h ed e c r e a s ei np r o g e s t e r o n ee x p e r i e n c e do nd a y2b y
heifers receiving GnRH in response to PGF2α is in agreement
with previous data reported by our laboratory. In that
study [6], it was clearly demonstrated that GnRH prevents
total luteolysis in cattle when injected right immediately
after PGF2α and consequently maintaining high levels of
progesterone for a period of 10 days. Furthermore, images
obtained in the present study also revealed the anti-luteolytic
actions of GnRH when concurrently injected with PGF2α.
Heifers in the PGF+GnRH+hCG group were the only
group experiencing a signiﬁcant increase in plasma proges-
terone on day 7 after the decline of this hormone in response
to PGF2α. This was the case when considering all heifers
in the group or for just those ovulating within the ﬁrst 8
days of the trial. Additionally, these animals experienced an
earlier ovulation compared to the other two experimental
groups; consequently, this group had an older corpus luteum
at day 7 which was active enough to establish the diﬀerence
observedinprogesteroneconcentrations.Ontheotherhand,
plasma progesterone concentrations observed in heifers in
the PGF+GnRH group remained steady after the PGF2α and
GnRH treatments. This may be attributed to the eﬀects of
GnRH previously observed by our laboratory. We reported
that GnRH impairs luteolysis in dairy heifers when injected
concurrently with PGF2α [6].
No signiﬁcant diﬀerences were detected on days 0 and
2( P>. 00) in progesterone concentrations between the
three groups. Heifers in the PGF+GnRH+hCG group
had signiﬁcant higher levels of this hormone than the
PGF+GnRH animals on day 7. On the other hand, there
was only a trend toward higher progesterone levels in heifers
receiving hCG when compared to PGF animals on that same
day of this study. The diﬀerence observed in progesterone
levels on day 7 between the two groups receiving GnRH was
mainly the result of an early ovulation and consequently due
to the presence of a more mature luteal tissue; however, the
restraining eﬀects on progesterone secretion exerted by the
e x o g e n o u sG n R Ho nl u t e a lt i s s u ei nt h eP G F+G n R Hg r o u p
also contributed to this diﬀerence. These GnRH haltering
eﬀects were not present in the group of heifers receiving only
PGF; consequently, it resulted in a more active progesterone
secretion by the luteal tissues of these animals. Therefore, the
diﬀerence in progesterone levels on day 7 between the PGF
and the PGF+GnRH+hCG was smaller and consequently
not signiﬁcantly diﬀerent.
Estrogen concentrations were not aﬀected by any of the
three experimental treatments (P>. 05). However, other
investigators [35]h a v eo b s e r v e da ni n c r e a s ei ne s t r o g e na f t e r
luteolysisincattlewhichcouldhavebeenreﬂectedinthePGF
a n i m a l so ft h i ss t u d y .
5. Conclusion
This data suggests that treatment of PGF2α concurrently
with GnRH followed 48h later with hCG further accelerates
follicular growth, advancing follicular growth to ovulation.
This can be evidenced by the sharp increase in progesterone
observed after hCG (day 7) as the result of an early ovulation
andconsequentlyduetothepresenceofamorematureluteal
tissue.AuthorsofthispaperadditionallyconcludedthathCG
induces ovulation at progesterone levels higher than those
previously reported to prevent it [7]. Furthermore, these
research ﬁndings indicate that systemic progesterone does
not seem to impair the ability of hCG to induce ovulation in
cattle. This data also suggests a potential application of hCG
in hormonal protocols designed to time ovulation in cattle.6 Veterinary Medicine International
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